A Single-Center, Retrospective Study of Bevacizumab-Containing Neoadjuvant Chemotherapy followed by Interval Debulking Surgery for Ovarian Cancer

PURPOSE: We evaluated whether adding bevacizumab to current platinum-based chemotherapy could improve clinical outcomes without affecting safety. MATERIALS AND METHODS: We retrospectively reviewed medical records of patients with pathologically confirmed ovarian cancer who received neoadjuvant chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Junsik, Eoh, Kyung Jin, Nam, Eun Ji, Kim, Sunghoon, Kim, Sang Wun, Kim, Young Tae, Lee, Jung-Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105404/
https://www.ncbi.nlm.nih.gov/pubmed/32233170
http://dx.doi.org/10.3349/ymj.2020.61.4.284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105404/
https://www.ncbi.nlm.nih.gov/pubmed/32233170
http://dx.doi.org/10.3349/ymj.2020.61.4.284

Ejemplares similares